BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Controlled attenuation parameter
1
Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital
4/25/2025 8:23:05 AM | Browse: 104 | Download: 465
2
Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients
6/7/2023 6:39:13 AM | Browse: 428 | Download: 1687
3
Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study
12/27/2021 5:24:01 AM | Browse: 726 | Download: 2022
4
Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
12/30/2020 1:59:10 PM | Browse: 768 | Download: 2216
5
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
11/27/2020 9:27:48 AM | Browse: 796 | Download: 2225
6
Ultrasound-based techniques for the diagnosis of liver steatosis
10/28/2019 11:23:12 AM | Browse: 1283 | Download: 2028
7
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
9/7/2019 4:43:36 AM | Browse: 1143 | Download: 2462
8
Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
8/23/2016 6:33:00 PM | Browse: 1366 | Download: 2137
9
Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan®)
11/11/2015 1:33:00 PM | Browse: 1736 | Download: 2420
10
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients
8/28/2014 5:50:00 PM | Browse: 1490 | Download: 1747
11
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis
8/26/2014 4:36:00 PM | Browse: 1071 | Download: 1831
12
Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B
8/18/2014 5:14:00 PM | Browse: 1035 | Download: 1823
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345